Literature DB >> 14642993

Why does surgery fail to cure limbic epilepsy? Seizure functional anatomy may hold the answer.

Edward H Bertram1.   

Abstract

Surgery for the mesial temporal lobe epilepsy syndrome is highly effective in controlling seizures in as many as 80% of the patients who undergo this procedure. However, the majority of the patients with successful operations still require medications to control their seizures. Only a small minority are able to stop medications and remain seizure free, patients who would be considered cured. Why are so few patients cured by this procedure? The answer may lie in the relation of the critical seizure circuits to the tissue that is actually resected. In this paper we will discuss two hypotheses for the functional anatomy of limbic epilepsy in light of what is known about the pathology and physiology of limbic epilepsy. Combining the clinical and scientific observations with these constructs for seizure initiation may lead us to a better understanding of this particular epilepsy syndrome as well as to more effective surgical approaches.

Entities:  

Mesh:

Year:  2003        PMID: 14642993     DOI: 10.1016/j.eplepsyres.2003.10.003

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  4 in total

1.  The hyperinhibition hypothesis in epileptogenesis: an assessment of the evidence.

Authors:  F Edward Dudek
Journal:  Epilepsy Curr       Date:  2006 Jan-Feb       Impact factor: 7.500

Review 2.  Neuronal circuits in epilepsy: do they matter?

Authors:  Edward H Bertram
Journal:  Exp Neurol       Date:  2012-02-08       Impact factor: 5.330

3.  Display of consistent ictal networks in refractory mesial temporal lobe epilepsy.

Authors:  G U Martz; S E Johnson; X Liu; B J Wolf; J L Hudson; M Quigg
Journal:  Clin Neurophysiol       Date:  2013-04-29       Impact factor: 3.708

4.  Widespread neocortical abnormalities in temporal lobe epilepsy with and without mesial sclerosis.

Authors:  S G Mueller; K D Laxer; J Barakos; I Cheong; P Garcia; M W Weiner
Journal:  Neuroimage       Date:  2009-02-26       Impact factor: 6.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.